Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Kang, Ran ^a,b   Zhou, Yan ^c   Tan, Shuang ^c,d   Zhou, Guangqian ^d   Aagaard, Lars ^c   Xie, Lin ^b   Bünger, Cody ^a   Bolund, Lars ^c   Luo, Yonglun ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c AARHUS UNIVERSITY   (Denmark)

^d Shenzhen University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD11B ANTIGEN; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL SURFACE MARKER; DNA METHYLTRANSFERASE 3B; ENDOGLIN; GROWTH DIFFERENTIATION FACTOR 3; HERMES ANTIGEN; HLA DR ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2;

ADIPOCYTE; ADIPOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CHONDROGENESIS; CONTROLLED STUDY; CRIPTO GENE; DNMT3B GENE; DPPA4 GENE; FLOW CYTOMETRY; GDF3 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIN28A GENE; MESENCHYME; OCT4 GENE; OSTEOBLAST; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAL4 GENE; SOX2 GENE; UTF1 GENE; CELL CULTURE; CELL LINE; CYTOLOGY; GENETICS; HEK293 CELL LINE; INDUCED PLURIPOTENT STEM CELL; LENTIVIRINAE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ADIPOGENESIS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHONDROGENESIS; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS;

EID: 84939237036     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0137-7     Document Type: Article

References (45)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-9. doi: 10.1038/nature00870.
2. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581-7.
3. Li WJ, Tuli R, Huang X, Laquerriere P, Tuan RS. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials. 2005;26:5158-66. doi: 10.1016/j.biomaterials.2005.01.002.
4. Kang R, Luo Y, Zou L, Xie L, Lysdahl H, Jiang X, et al. Osteogenesis of human induced pluripotent stem cells derived mesenchymal stem cells on hydroxyapatite contained nanofibers. RSC Adv. 2014;4:5734-9. doi: 10.1039/C3RA44181D.
5. Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V, Zichner L, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng. 2004;32:112-22.
6. He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells. 2007;25:69-77. doi: 10.1634/stemcells.2006-0335.
7. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278-94.
8. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72. doi: 10.1016/j.cell.2007.11.019.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76. doi: 10.1016/j.cell.2006.07.024.
10. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4:381-4. doi: 10.1016/j.stem.2009.04.005.
11. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618-30.
12. Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341:651-4. doi: 10.1126/science.1239278.
13. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Lam FF, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121:1113-23. doi: 10.1161/CIRCULATIONAHA.109.898312.
14. Bilousova G, du Jun H, King KB, De Langhe S, Chick WS, Torchia EC, et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells. 2011;29:206-16. doi: 10.1002/stem.566.
15. Villa-Diaz LG, Brown SE, Liu Y, Ross AM, Lahann J, Parent JM, et al. Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells. 2012;30:1174-81. doi: 10.1002/stem.1084.
16. Zou L, Luo Y, Chen M, Wang G, Ding M, Petersen CC, et al. A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep. 2013;3:2243. doi: 10.1038/srep02243.
17. Papapetrou EP, Sadelain M. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat Protoc. 2011;6:1251-73. doi: 10.1038/nprot.2011.374.
18. Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, Tirunagari LM, et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol. 2011;29:73-8. doi: 10.1038/nbt.1717.
19. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163-73. doi: 10.1016/j.mad.2007.12.002.
20. Nerurkar NL, Baker BM, Sen S, Wible EE, Elliott DM, Mauck RL. Nanofibrous biologic laminates replicate the form and function of the annulus fibrosus. Nat Mater. 2009;8:986-92. doi: 10.1038/nmat2558.
21. Lysdahl H, Baatrup A, Nielsen AB, Foldager CB, Bunger C. Phenol red inhibits chondrogenic differentiation and affects osteogenic differentiation of human mesenchymal stem cells in vitro. Stem Cell Rev. 2013;9:132-9. doi: 10.1007/s12015-012-9417-0.
22. LeGeros RZ, Craig RG. Strategies to affect bone remodeling: osteointegration. J Bone Miner Res. 1993;8:S583-96. doi: 10.1002/jbmr.5650081328.
23. Quintanilla Jr RH, Asprer JS, Vaz C, Tanavde V, Lakshmipathy U. CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS One. 2014;9:e85419. doi: 10.1371/journal.pone.0085419.
24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7. doi: 10.1080/14653240600855905.
25. Chung MT, Liu C, Hyun JS, Lo DD, Montoro DT, Hasegawa M, et al. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells. Tissue Eng Part A. 2013;19:989-97. doi: 10.1089/ten.TEA.2012.0370.
26. Penick KJ, Solchaga LA, Welter JF. High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells. Biotechniques. 2005;39:687-91.
27. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106:15768-73. doi: 10.1073/pnas.0906894106.
28. Phillips MD, Kuznetsov SA, Cherman N, Park K, Chen KG, McClendon BN, et al. Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays. Stem Cells Trans Med. 2014;3:867-78. doi: 10.5966/sctm.2013-0154.
29. Giuliani M, Oudrhiri N, Noman ZM, Vernochet A, Chouaib S, Azzarone B, et al. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood. 2011;118:3254-62. doi: 10.1182/blood-2010-12-325324.
30. Jeong J, Shin K, Lee SB, Lee DR, Kwon H. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells. Exp Mol Pathol. 2014;97:253-8. doi: 10.1016/j.yexmp.2014.08.001.
31. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121:1113-23. doi: 10.1161/CIRCULATIONAHA.109.898312.
32. Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Trans Med. 2012;1:83-95. doi: 10.5966/sctm.2011-0022.
33. Whitworth DJ, Frith JE, Frith TJ, Ovchinnikov DA, Cooper-White JJ, Wolvetang EJ. Derivation of mesenchymal stromal cells from canine induced pluripotent stem cells by inhibition of the TGFbeta/activin signaling pathway. Stem Cells Dev. 2014. doi: 10.1089/scd.2013.0634.
34. Hoogduijn MJ, Crop MJ, Peeters AM, Van Osch GJ, Balk AH, Ijzermans JN, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007;16:597-604. doi: 10.1089/scd.2006.0110.
35. Hu Y, Liao L, Wang Q, Ma L, Ma G, Jiang X, et al. Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med. 2003;141:342-9. doi: 10.1016/S0022-2143(03)00022-2.
36. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24:1294-301. doi: 10.1634/stemcells.2005-0342.
37. Deyle DR, Khan IF, Ren G, Wang PR, Kho J, Schwarze U, et al. Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther. 2012;20:204-13. doi: 10.1038/mt.2011.209.
38. Koyama N, Miura M, Nakao K, Kondo E, Fujii T, Taura D, et al. Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells Dev. 2013;22:102-13. doi: 10.1089/scd.2012.0127.
39. Guzzo RM, Gibson J, Xu RH, Lee FY, Drissi H. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J Cell Biochem. 2013;114:480-90. doi: 10.1002/jcb.24388.
40. Zhao Q, Gregory CA, Lee RH, Reger RL, Qin L, Hai B, et al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2015;112:530-5. doi: 10.1073/pnas.1423008112.
41. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A. 2009;15:1897-907. doi: 10.1089/ten.tea.2008.0351.
42. Hynes K, Menicanin D, Mrozik K, Gronthos S, Bartold PM. Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. Stem Cells Dev. 2014;23:1084-96. doi: 10.1089/scd.2013.0111.
43. Kuci Z, Seiberth J, Latifi-Pupovci H, Wehner S, Stein S, Grez M, et al. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression. Haematologica. 2013;98:1609-16. doi: 10.3324/haematol.2013.092700.
44. Wei H, Tan G, Manasi, Qiu S, Kong G, Yong P, et al. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res. 2012;9:87-100. doi: 10.1016/j.scr.2012.04.003.
45. Hynes K, Menicanin D, Gronthos S, Bartold MP. Differentiation of iPSC to mesenchymal stem-like cells and their characterization. Methods Mol Biol. 2014. doi: 10.1007/7651-2014-142.